Tuesday, January 21, 2014

Bought Some More NeuroMetrix (NURO) at $2.50

NeuroMetrix (NURO) announced today (02014.01.21) that "Jiro Nakamura, M.D., Ph.D., has joined its Scientific Advisory Board. Dr. Nakamura is Professor, Division of Diabetes, Department of Internal Medicine, Diabetes Center at the Aichi Medical University School of Medicine in Nagakute, Japan." The NeuroMetrix press release contained the following.
Dr. Nakamura’s position in the Japan medical profession and understanding of local medical practice will be a valuable near-term source of advice and guidance as we move toward the launch of NC-stat DPNCheck in the Japanese market during 2014.

The NeuroMetrix press release stated: "Dr. Nakamura is considered a leader in the field of diabetes research and treatment." I find this believable; consequently, I find it difficult to believe Dr. Nakamura would become associated with a losing company.

NURO closed on 02014.01.17 at $2.61. 52-week range: $1.47 - $4.25.

No comments:

Post a Comment